Crinetics Pharmaceuticals, Inc. (CRNX) Social Stream



Crinetics Pharmaceuticals, Inc. (CRNX): $45.80

1.37 (+3.08%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

CRINETICS PHARMACEUTICALS INC (CRNX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRNX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $42 $35 $37.5 $37.92 -1.11%
2021-11-23 5 $68 $35 $43.4 $37.92 14.45%
2022-02-02 5 $68 $35 $43.333 $37.92 14.27%
2022-05-16 6 $68 $35 $43.833 $37.92 15.59%
2022-05-26 6 $68 $35 $44.333 $37.92 16.91%
2022-08-15 6 $68 $35 $44.5 $37.92 17.35%
2022-11-18 5 $44 $35 $39.4 $37.92 3.9%
2023-01-13 5 $44 $35 $38.5 $37.92 1.53%
2023-03-01 6 $44 $35 $38.5 $37.92 1.53%
2023-03-10 6 $44 $35 $38.8 $37.92 2.32%
2023-03-26 7 $44 $35 $38.8 $37.92 2.32%
2023-03-27 7 $57 $35 $41.833 $37.92 10.32%
2023-05-05 8 $57 $35 $43.714 $37.92 15.28%
2023-06-08 8 $57 $35 $46 $37.92 21.31%
2023-08-08 7 $57 $35 $46 $37.92 21.31%
2023-08-09 7 $57 $32 $44 $37.92 16.03%
2023-08-31 8 $57 $32 $43.5 $37.92 14.72%
2023-09-11 8 $60 $32 $44.625 $37.92 17.68%
2023-09-12 9 $60 $33 $46.555 $37.92 22.77%
2023-10-23 8 $60 $33 $45.875 $37.92 20.98%
2023-11-08 9 $60 $33 $46.333 $37.92 22.19%
2023-11-10 10 $57 $33 $46 $37.92 21.31%
2023-12-19 10 $57 $42 $47.555 $37.92 25.41%
2023-12-20 11 $62 $35 $46.8 $37.92 23.42%

The Trend in the Analyst Price Target


Over the past 20 months, CRNX's average price target has gone up $1.89.

CRNX reports an average of 100.41% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-09 6 44 35 38.800 18.20 113.19%
2023-03-27 8 57 35 41.833 15.93 162.61%
2023-05-05 9 57 35 43.714 22.35 95.59%
2023-08-08 7 57 35 46.000 17.30 165.9%
2023-08-31 8 57 32 43.500 17.32 151.15%

CRNX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.18 10 0 1 0 0 11

The Trend in the Broker Recommendations


Over the past 26 weeks, CRNX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how CRINETICS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3292.88% of that group.
  • CRINETICS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 2944.25% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, CRINETICS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 818.87% of them.
  • In terms of how CRINETICS PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1174.15% of that group.

In the Pharmaceutical Products industry, KZR, VRCA, and ITRM are the three stocks most similar to CRINETICS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CRNX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!